Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Dapagliflozin in Adult Patients With a Systemic Right Ventricle

NCT05717257 is registered in ClinicalTrials.gov with Monaldi Hospital as lead sponsor.

NCT NCT05717257
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05717257 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Dapagliflozin in Adult Patients With a Systemic Right Ventricle
Lead sponsor
Monaldi Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
August 1, 2022
Completion date
August 31, 2024
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dapagliflozin adverse reaction, efficacy, systemic right ventricle